These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6587177)

  • 1. In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test.
    Tsukamura M
    Microbiol Immunol; 1983; 27(12):1129-32. PubMed ID: 6587177
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L; Naumann P; Crea A
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of Mycobacterium gordonae from Mycobacterium scrofulaceum and Mycobacterium szulgai by susceptibility to enoxacin (antimycobacterial activity of enoxacin).
    Tsukamura M
    Microbiol Immunol; 1986; 30(9):931-3. PubMed ID: 3467156
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
    Texier-Maugein J; Mormède M; Fourche J; Bébéar C
    Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
    Davies S; Sparham PD; Spencer RC
    J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.
    Rastogi N; Goh KS; David HL
    Ann Inst Pasteur Microbiol; 1988; 139(2):233-7. PubMed ID: 3165641
    [No Abstract]   [Full Text] [Related]  

  • 7. Differentiation of Mycobacterium chelonei from M. fortuitum by ciprofloxacin susceptibility.
    Collins CH; Yates MD; Uttley AH
    J Hyg (Lond); 1985 Dec; 95(3):619-21. PubMed ID: 2936800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of five new quinolones against cultivable mycobacteria.
    Pattyn SR; Van Caekenberghe DL; Verhoeven JR
    Eur J Clin Microbiol; 1987 Oct; 6(5):572-3. PubMed ID: 3125049
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
    Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antibiotics, resorcinomycins A and B: antibacterial activity of resorcinomycin A against mycobacteria in vitro.
    Masaki S; Konishi T; Tsuji N; Shoji J
    J Antibiot (Tokyo); 1989 Mar; 42(3):463-6. PubMed ID: 2708139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differentiation between mycobacterial species by the susceptibility test to ciprofloxacin--comparison of antimycobacterial spectra between ofloxacin and ciprofloxacin].
    Tsukamura M; Mizuno S
    Kekkaku; 1986 Jun; 61(6):357-9. PubMed ID: 2943929
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
    Arai H; Nakajima H; Kaminaga Y
    J Dermatol; 1990 Jun; 17(6):370-4. PubMed ID: 2384640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for determining the antimicrobial susceptibility of mycobacteria.
    Alcaide F; Esteban J; González-Martin J; Palacios JJ
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):529-535. PubMed ID: 27236235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
    Berlin OG; Young LS; Floyd-Reising SA; Bruckner DA
    Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
    Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
    J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
    Saito H; Sato K; Tomioka H; Watanabe T
    Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537
    [No Abstract]   [Full Text] [Related]  

  • 18. Differentiation of Mycobacterium nonchromogenicum from Mycobacterium terrae and Mycobacterium triviale by tests for susceptibility to ofloxacin (DL 8280) and by the developing pattern of petroleum-ether soluble sulfolipids on TLC.
    Tsukamura M; Mizuno S; Toyama H
    Microbiol Immunol; 1985; 29(4):365-70. PubMed ID: 2410764
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro susceptibility of Mycobacterium fortuitum to non-antituberculous antibacterial agents.
    Casal MJ; Rodriguez FC
    Ann Microbiol (Paris); 1983; 134A(1):73-8. PubMed ID: 6847037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.
    Casal MJ; Rodriguez FC; Benavente MC
    Antimicrob Agents Chemother; 1985 Feb; 27(2):282-3. PubMed ID: 3857020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.